|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.13 USD | -2.67% |
|
-6.04% | -23.01% |
| Dec. 10 | Wolfe Research Upgrades Bruker to Outperform From Peer Perform, $60 Price Target | MT |
| Dec. 10 | Bruker Receives $25 Million in European Orders for High-Performance Magnetic Resonance Systems | MT |
Company Valuation: Bruker Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 8,288 | 12,725 | 10,053 | 10,170 | 8,887 | 6,857 | - | - |
| Change | - | 53.54% | -21% | 1.17% | -12.62% | -22.84% | - | - |
| Enterprise Value (EV) 1 | 8,400 | 12,991 | 10,627 | 10,964 | 10,798 | 8,334 | 8,121 | 7,922 |
| Change | - | 54.65% | -18.2% | 3.17% | -1.51% | -22.81% | -2.56% | -2.45% |
| P/E ratio | 53.1x | 46.4x | 34.3x | 25.3x | 77.1x | -111x | 71.7x | 34x |
| PBR | 8.58x | 12x | 9x | 7.75x | 4.99x | 2.74x | 2.58x | 2.39x |
| PEG | - | 0.6x | 3.45x | 0.6x | -1x | 1x | -0x | 0x |
| Capitalization / Revenue | 4.17x | 5.26x | 3.97x | 3.43x | 2.64x | 2.01x | 1.97x | 1.88x |
| EV / Revenue | 4.23x | 5.37x | 4.2x | 3.7x | 3.21x | 2.44x | 2.34x | 2.17x |
| EV / EBITDA | 23.2x | 24.9x | 19.1x | 17.9x | 17.9x | 15.4x | 12.8x | 11.5x |
| EV / EBIT | 26.5x | 27.6x | 21x | 20.1x | 20.8x | 18.9x | 15.2x | 13.5x |
| EV / FCF | 35.7x | 68.2x | 73.2x | 45.1x | 80.7x | 325x | 24.1x | 26.9x |
| FCF Yield | 2.8% | 1.47% | 1.37% | 2.22% | 1.24% | 0.31% | 4.14% | 3.71% |
| Dividend per Share 2 | 0.16 | 0.16 | 0.2 | 0.2 | 0.2 | 0.174 | 0.2223 | 0.2971 |
| Rate of return | 0.3% | 0.19% | 0.29% | 0.27% | 0.34% | 0.39% | 0.49% | 0.66% |
| EPS 2 | 1.02 | 1.81 | 1.99 | 2.9 | 0.76 | -0.4077 | 0.6293 | 1.326 |
| Distribution rate | 15.7% | 8.84% | 10.1% | 6.9% | 26.3% | -42.7% | 35.3% | 22.4% |
| Net sales 1 | 1,988 | 2,418 | 2,531 | 2,964 | 3,366 | 3,417 | 3,474 | 3,651 |
| EBITDA 1 | 361.9 | 521.9 | 556.5 | 614.1 | 602.6 | 542.1 | 635.4 | 690.3 |
| EBIT 1 | 317.2 | 470.2 | 505.6 | 546.3 | 518 | 441.3 | 535.3 | 588.4 |
| Net income 1 | 157.8 | 277.1 | 296.6 | 427.2 | 113.1 | -57.46 | 159.6 | 195 |
| Net Debt 1 | 112.7 | 266 | 573.7 | 793.2 | 1,911 | 1,477 | 1,264 | 1,065 |
| Reference price 2 | 54.13 | 83.91 | 68.35 | 73.48 | 58.62 | 45.13 | 45.13 | 45.13 |
| Nbr of stocks (in thousands) | 153,108 | 151,655 | 147,083 | 138,411 | 151,598 | 151,941 | - | - |
| Announcement Date | 2/16/21 | 2/11/22 | 2/9/23 | 2/13/24 | 2/13/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -110.7x | 2.44x | 15.37x | 0.39% | 6.86B | ||
| 32.06x | 5.5x | 21.78x | 0.29% | 215B | ||
| 71.91x | 18.86x | 44.03x | -.--% | 192B | ||
| 43.51x | 7.07x | 22.82x | 0.55% | 160B | ||
| 44.83x | 7.28x | 23.75x | -.--% | 137B | ||
| 20.73x | 2.48x | 12.06x | 2.31% | 57.67B | ||
| 36.61x | 7.44x | 24.66x | -.--% | 48.21B | ||
| 31.31x | 5.95x | 21.21x | 0.7% | 39.54B | ||
| 18.34x | 2.11x | 11.92x | 0.15% | 38.25B | ||
| 24.05x | 6.34x | 16.41x | 0.96% | 36.77B | ||
| Average | 21.27x | 6.55x | 21.40x | 0.53% | 93.17B | |
| Weighted average by Cap. | 41.70x | 8.59x | 25.70x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BRKR Stock
- Valuation Bruker Corporation
Select your edition
All financial news and data tailored to specific country editions
















